Litcius/Paper detail

Effectiveness of bi-monthly long-acting injectable cabotegravir and rilpivirine as maintenance treatment for HIV-1 in the Netherlands: results from the Dutch ATHENA national observational cohort

Vita W. Jongen, Ferdinand W N M Wit, Anders Boyd, Arne van Eeden, Annemarie E. Brouwer, Robert Soetekouw, Rachida el Moussaoui, Janneke E. Stalenhoef, Kim Sigaloff, Tatiana Mudrikova, Jet Gisolf, David Burger, Annemarie M. J. Wensing, Marc van der Valk

2025The Lancet HIV15 citationsDOIOpen Access PDF

Topics & Concepts

RilpivirineMedicineObservational studyHuman immunodeficiency virus (HIV)CohortCohort studyEnvironmental healthInternal medicineFamily medicineAntiretroviral therapyViral loadHIV-related health complications and treatmentsHIV, Drug Use, Sexual RiskHIV/AIDS Research and Interventions
Effectiveness of bi-monthly long-acting injectable cabotegravir and rilpivirine as maintenance treatment for HIV-1 in the Netherlands: results from the Dutch ATHENA national observational cohort | Litcius